StockData
ALX Oncology Holdings Inc logo

ALX Oncology Holdings Inc (ALXO) stock

ALXONasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 3/30
$1.00+0.00 (+0.50%)

Close on Nov 17, 2026Market cap $138.97MP/E –Yield –

ALX Oncology operating margin

Operating margin is operating income as a percentage of revenue.

ALX Oncology's operating margin for the twelve months ending Dec 31, 2020 was -3694.0%. For fiscal 2020 it was -3694.0%, against -400.0% the year before.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2020Dec 31, 2020-3694.0%−3294.0
FY2019Dec 31, 2019-400.0%+262.0
FY2018Dec 31, 2018-662.0%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q2 FY2020Jun 30, 2020-2046.9%−1723.4
Q1 FY2020Mar 31, 2020-800.3%–
Q4 FY2019Dec 31, 2019-637.5%–
Q3 FY2019Sep 30, 2019-241.6%–
Q2 FY2019Jun 30, 2019-323.5%–

More ALX Oncology figures

See a number that looks wrong?